SCHEMBL22087409

SCHEMBL22087409

c1ccc(-c2cc(-c3c4ccccc4c(-c4ccc(-c5ccc(-c6ccc(-c7ccc(-c8c9ccccc9c(-c9ccc(-c%10cccc%11oc%12ccccc%12c%10%11)c%10ccccc9%10)c9ccccc89)cc7)cc6)c6oc7ccccc7c56)cc4)c4ccccc34)c3ccccc3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 2/20 0.36
▸ CDC14A Q9UNH5 2/20 0.36
▸ ALOX5 P09917 2/20 0.36
▸ GPR84 Q9NQS5 2/20 0.33
▸ HSD17B1 P14061 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32
▸ BACE1 P56817 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ CSNK2A2 P19784 1/20 0.31
▸ CSNK2B P67870 1/20 0.31
▸ PIM3 Q86V86 1/20 0.31
▸ PIM2 Q9P1W9 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ MPI P34949 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ANPEP P15144 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22062621 0.91 GPR84 (0.38) ALOX5GPR84HSD17B1HSD17B2BACE1
SCHEMBL23504645 0.90 CDC14B (0.36) CDC14BCDC14AALOX5GPR84HSD17B1
SCHEMBL22178611 0.90 CDC14B (0.36) CDC14BCDC14AALOX5GPR84HSD17B1
SCHEMBL23504639 0.89 ALOX5 (0.38) CDC14BCDC14AALOX5GPR84HSD17B1
SCHEMBL24922915 0.88 ALOX5 (0.36) CDC14BCDC14AALOX5GPR84HSD17B1
SCHEMBL23504673 0.88 ALOX5 (0.45) CDC14BCDC14AALOX5GPR84HSD17B1
SCHEMBL22087408 0.88 ALOX5 (0.36) CDC14BCDC14AALOX5GPR84HSD17B1
SCHEMBL22088294 0.87 ALOX5 (0.39) CDC14BCDC14AALOX5GPR84BACE1
SCHEMBL22088904 0.87 ALOX5 (0.37) CDC14BCDC14AALOX5GPR84HSD17B1
SCHEMBL23060381 0.86 ALOX5 (0.40) CDC14BCDC14AALOX5GPR84BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200181160-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181160-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE AHR, EMC2, NFE2L2 CDC14B 4362/4885CDC14A 4495/4885ALOX5 2553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback